Cypress Point Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$212K Buy
+504
New +$201K 0.02% 149
2021
Q4
– Sell
-720
Closed -$153K – 37
2021
Q3
$153K Hold
720
– – 0.11% 32
2021
Q2
$176K Buy
+720
New +$177K 0.13% 32

Other funds holding AMGN

Cypress Point Wealth Management's AMGN Position: Q3 2026 in Review

Cypress Point Wealth Management opened a new position in Amgen (AMGN) in Q3 2026: 504 shares worth $212K. The stake represents 0.02% of the portfolio and ranks #149 among its holdings. This is a return to the name: Cypress Point Wealth Management previously reported a position in AMGN as recently as Q3 2021.

Cypress Point Wealth Management first reported a position in AMGN in Q2 2021 and has held it in 3 quarters since. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Cypress Point Wealth Management held 504 shares of Amgen worth $212K as of Q3 2026.
  • Amgen was a new Cypress Point Wealth Management position in Q3 2026.
  • Amgen made up 0.02% of Cypress Point Wealth Management's portfolio in Q3 2026, its #149 holding.
  • Cypress Point Wealth Management first reported a position in Amgen in Q2 2021 and has held it in 3 quarters since.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Cypress Point Wealth Management's 13F filing for Q3 2026, filed 2 Nov 2026.